<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="24">
  <stage>Registered</stage>
  <submitdate>13/07/2005</submitdate>
  <approvaldate>13/07/2005</approvaldate>
  <actrnumber>ACTRN12605000007639</actrnumber>
  <trial_identification>
    <studytitle>A randomised controlled trial of hot water (45.C) immersion versus ice packs for Chironex fleckeri stings</studytitle>
    <scientifictitle>A randomised controlled trial of hot water (45.C) immersion versus ice packs to reduce pain by a clinically significant amount on a visual analogue score in chironex fleckeri stings</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil Known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Chrironex fleckeri (major box jellyfish) stings/envenoming</healthcondition>
    <conditioncode>
      <conditioncode1>Other</conditioncode1>
      <conditioncode2 />
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Hot water immersion at 45 degrees Celsis for 30 minutes</interventions>
    <comparator>Ice packs for the same duration (current standard of care)</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>A reduction in pain defined on the visual analogue score (VAS) as "much better" or clinically significant according to a modification of Bird and Dickson.</outcome>
      <timepoint>At 30 minutes</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Cross-over to the alternate treatment.</outcome>
      <timepoint>At 30 minutes</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Repeat treatment forrecurrent/ongoing pain.</outcome>
      <timepoint>60 minutes</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Use of opiate analgesia.</outcome>
      <timepoint>at any time</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>LOS in ED</outcome>
      <timepoint>this outcome is a time outcome</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Development of regional/radiating pain.</outcome>
      <timepoint>any time after the sting</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Frequency of systemic features.</outcome>
      <timepoint>after the sting</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Proportion with recurrent pain.</outcome>
      <timepoint>At 1hr, 24hr.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Proportion with papular urticaria.</outcome>
      <timepoint>At 7 to 10 days.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>All patients presenting with a major box jellyfish (Chironex fleckeri) sting.</inclusivecriteria>
    <inclusiveminage>8</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Severe envenoming requiring resuscitation or antivenom, a sting clinically consistent with Irukandji syndrome and not C. fleckeri, stings to the eye, an initial abnormal ECG, initial hypotension: Systolic BP &lt;90mmHg</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Open. The treatment allocation will be concealed in the envelope until after the patient has consented to the study</concealment>
    <sequence>Randomised by computer in sequentially numbered envelopes in variable block sizes.</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/10/2005</anticipatedstartdate>
    <actualstartdate>27/11/2005</actualstartdate>
    <anticipatedenddate />
    <actualenddate>25/10/2008</actualenddate>
    <samplesize>55</samplesize>
    <actualsamplesize>46</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>30/10/2008</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NT</recruitmentstate>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Menzies School of Health Research, Charles Darwin University, Darwin</primarysponsorname>
    <primarysponsoraddress>as above</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>National Health &amp; Medical Research Council Clinical Career Development Award</fundingname>
      <fundingaddress>NHMRC</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>Nil</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The study was completed about 7 years ago but due to a lack of funding and two investigators not being on site it has not been analysed. The study now has been analysed and will be presented in November 2016.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Darwin Hospital and Menzies School of Health Rersearch</ethicname>
      <ethicaddress />
      <ethicapprovaldate>8/07/2005</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate>30/05/2016</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Dr Geoffrey Isbister</name>
      <address>Menzies School of Health Research
PO Box 41096
Casuarina Darwin NT 0811</address>
      <phone>+61 2 89228888</phone>
      <fax />
      <email>gsbite@ferntree.com</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Dr Geoffrey Isbister</name>
      <address>Menzies School of Health Research
PO Box 41096 
Casuarina Darwin NT 0811</address>
      <phone>+61 2 89228888</phone>
      <fax />
      <email>gsbite@ferntree.com</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Geoffrey Isbister</name>
      <address>Calvary Mater Newcastle
Waratah NSW 2298</address>
      <phone>0438466471</phone>
      <fax />
      <email>geoff.isbister@gmail.com</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>